Walgreens Boots Alliance (WBA) reported Q3 FY2024 earnings of $0.63 per share (versus $1.00 per share in Q3 FY2023), missing analysts’ consensus estimate of $0.68 per share.
The company’s quarterly revenues amounted to $36.400 bln (+2.8% y/y), beating analysts’ consensus estimate of $35.941 bln.
The company also lowered its FY2024 EPS guidance to $2.80-$2.95, down from its prior guidance of $3.20-$3.50, versus analysts’ consensus estimate of $3.20, citing challenging pharmacy industry trends and a worse-than-expected U.S. consumer environment.
WBA fell to $14.71 (-6.07%) in pre-market trading.